AstraZeneca Gets FDA Approval For Once-Daily Seroquel

The Food and Drug Administration approved AstraZeneca's once-daily schizophrenia drug, Seroquel XR.

Seroquel is AstraZeneca's second-biggest drug, with global sales of $3.4 billion last year.

The approval is a welcome boost to AstraZeneca after the recent high-profile failures of two new drugs for stroke and heart disease.

The company is looking to established drugs such as Seroquel to keep the business growing while it seeks additional acquisitions.

In addition, the original immediate-release formulation of Seroquel faces patent threats, with a case potentially coming to court next year in the United States.

Seroquel belongs to a class of drugs called atypical antipsychotics and is the most prescribed treatment of its kind in the United States. It is also used in patients with bipolar disorder.



Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • It would be nice to see above 200,000, says Dallas Fed President Richard Fisher, revealing what he hopes to see from Friday's jobs report.

  • Dallas Fed President Richard Fisher, discusses the Lone Star State's economic boom.

  • Things are getting better and if it continues, I personally believe we should move up the date of liftoff, says Dallas Fed President Richard Fisher, sharing his thoughts on tapering the Fed's easy money policy and when he expects to see interest rates increase.